EXAMINATION OF VENTAVIS (ILOPROST) INHALATION BEHAVIOR USING THE I-NEB AAD SYSTEM IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION WHEN SWITCHING THE ILOPROST NEBULIZER SOLUTION FOR INHALATION FROM 10 ΜG/ML (V10) TO 20 ΜG/ML (V20):